US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Prelude Therapeutics Inc

2.17

+0.15007.43%

Post-market: 2.08-0.0900-4.15%17:32 EST

Volume:221.75K

Turnover:471.29K

Market Cap:136.42M

PE:-1.48

High:2.21

Open:2.07

Low:1.98

Close:2.02

52wk High:4.22

52wk Low:0.6101

Shares:62.87M

Float Shares:2.50M

Volume Ratio:0.69

T/O Rate:8.86%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4708

EPS(LYR):-1.6776

ROE:-103.99%

ROA:-51.82%

PB:2.33

PE(LYR):-1.29

Loading ...

Overview Company News Filings

BUZZ-Prelude Therapeutics rises after FDA clears early-stage trial of blood cancer drug

BRIEF-Prelude Therapeutics Receives FDA Clearance Of Investigational New Drug Application (Ind) For Prt12396, A Mutant-Selective Jak2v617f Inhibitor

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (Ind) for PRT12396, a Mutant-Selective Jak2v617f Inhibitor

THOMSON REUTERS

Prelude Therapeutics Inc - to Dose First Patient by Q2 2026

THOMSON REUTERS

Prelude Therapeutics’ PRT2527 Trial Completion: What Investors Should Watch in Hematologic Oncology

Nasdaq Net Change Percentage Gainers & Losers

Prelude Therapeutics unveils strategic investor presentation on pipelines

Celsius Holdings Among 3 Value Stocks Trading Below Estimated Worth

Simply Wall St.

Bullish Prelude Therapeutics Insiders Rewarded As Their Investment Rises To US$2.75m

Simply Wall St.

ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards

THOMSON REUTERS

Prelude Therapeutics Files for Resale From Time to Time of up to 6.3 Mln Shares of Voting Common Stock by Selling Stockholder

THOMSON REUTERS

Prelude Therapeutics Unveils Preclinical MPN Program Data at ASH Annual Meeting

Penny Stocks To Consider In December 2025

Simply Wall St.

Prelude Therapeutics Advances Pipeline and Strengthens Financials

Prelude Therapeutics reports third quarter net loss of $19.7 million

BRIEF-Prelude Therapeutics Q3 EPS USD -0.26

Prelude Therapeutics Q3 Income From Operations USD -20.418 Million

THOMSON REUTERS

Top News Today/Canada: Barrick's Interim CEO Gets to Work

Prelude Therapeutics to Pause Development of Cancer Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRLD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRLD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRLD\",,,,,undefined,":{"symbol":"PRLD","market":"US","secType":"STK","nameCN":"Prelude Therapeutics Inc","latestPrice":2.17,"timestamp":1770411600000,"preClose":2.02,"halted":0,"volume":221753,"hourTrading":{"tag":"盘后","latestPrice":2.08,"preClose":2.17,"latestTime":"17:32 EST","volume":365,"amount":790.4697689999999,"timestamp":1770417177863,"change":-0.09,"changeRate":-0.041475,"amplitude":0.041475},"delay":0,"changeRate":0.07425742574257421,"floatShares":2502400,"shares":62865300,"eps":-1.470767,"marketStatus":"Post-Mkt","change":0.15,"latestTime":"02-06 18:14:12 EST","open":2.07,"high":2.21,"low":1.98,"amount":471294.53368899995,"amplitude":0.113861,"askPrice":2.3,"askSize":78,"bidPrice":2.08,"bidSize":26,"shortable":0,"etf":0,"ttmEps":-1.470767,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770426000000},"marketStatusCode":4,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":2.02,"preHourTrading":{"tag":"盘前","latestPrice":2.15,"preClose":2.02,"latestTime":"09:25 EST","volume":265,"amount":569.590046,"timestamp":1770387913273,"change":0.13,"changeRate":0.064356,"amplitude":0.039604},"postHourTrading":{"tag":"盘后","latestPrice":2.08,"preClose":2.17,"latestTime":"17:32 EST","volume":365,"amount":790.4697689999999,"timestamp":1770417177863,"change":-0.09,"changeRate":-0.041475,"amplitude":0.041475},"volumeRatio":0.693423,"impliedVol":1.6485,"impliedVolPercentile":0.8486},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRLD\",,,,,undefined,":{"symbol":"PRLD","floatShares":2502400,"roa":"-51.82%","roe":"-103.99%","lyrEps":-1.677614,"volumeRatio":0.693423,"shares":62865300,"dividePrice":0,"high":2.21,"amplitude":0.113861,"preClose":2.02,"low":1.98,"week52Low":0.6101,"pbRate":"2.33","psRate":"12.99","week52High":4.22,"institutionHeld":0,"latestPrice":2.17,"committee":-0.5,"eps":-1.470767,"divideRate":0,"volume":221753,"delay":0,"ttmEps":-1.470767,"open":2.07,"prevYearClose":2.9,"prevWeekClose":1.85,"prevMonthClose":1.85,"prevQuarterClose":2.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRLD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"PRLD","fiscalQuarterEnding":"2025/09","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-08-14","symbol":"PRLD","fiscalQuarterEnding":"2025/06","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-05-06","symbol":"PRLD","fiscalQuarterEnding":"2025/03","expectedEps":-0.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2025-03-10","symbol":"PRLD","fiscalQuarterEnding":"2024/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2024-11-06","symbol":"PRLD","fiscalQuarterEnding":"2024/09","expectedEps":-0.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRLD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRLD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1746507600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRLD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRLD","date":"2026-02-05","current":-1.475421,"percent":0.638752,"low":-86.969725,"twenty":-4.745021,"median":-2.093626,"eighty":-0.761005,"high":-0.264772,"avg":-6.066953,"sd":11.845605,"marketCap":189514153},"quantilePoints":[{"date":"2021-02-12","current":-84.408444,"twenty":-70.613573,"median":-48.816067,"eighty":-38.97969,"marketCap":4027802136},{"date":"2021-02-19","current":-73.006,"twenty":-70.970255,"median":-49.263626,"eighty":-39.060542,"marketCap":3483700296},{"date":"2021-02-26","current":-59.12765,"twenty":-70.697052,"median":-51.206322,"eighty":-39.166099,"marketCap":2821453216},{"date":"2021-03-05","current":-53.872281,"twenty":-70.647724,"median":-52.933144,"eighty":-39.413147,"marketCap":2570677493},{"date":"2021-03-12","current":-54.431968,"twenty":-70.617368,"median":-53.156672,"eighty":-39.851902,"marketCap":2597384654},{"date":"2021-03-19","current":-43.570722,"twenty":-70.009741,"median":-52.933144,"eighty":-40.343032,"marketCap":2480437654},{"date":"2021-03-26","current":-33.943242,"twenty":-69.085529,"median":-51.206322,"eighty":-39.466071,"marketCap":1932354850},{"date":"2021-04-01","current":-32.875294,"twenty":-68.817597,"median":-49.881838,"eighty":-39.058296,"marketCap":1871557586},{"date":"2021-04-09","current":-28.101402,"twenty":-67.860995,"median":-48.949202,"eighty":-37.65144,"marketCap":1599784739},{"date":"2021-04-16","current":-25.694532,"twenty":-67.488148,"median":-47.769922,"eighty":-36.390832,"marketCap":1462764038},{"date":"2021-04-23","current":-27.567428,"twenty":-67.018117,"median":-46.535476,"eighty":-34.588667,"marketCap":1569386106},{"date":"2021-04-30","current":-33.253081,"twenty":-66.875384,"median":-45.93774,"eighty":-33.40843,"marketCap":1893064649},{"date":"2021-05-07","current":-33.389496,"twenty":-66.304923,"median":-45.72453,"eighty":-32.950851,"marketCap":1900830599},{"date":"2021-05-14","current":-28.110318,"twenty":-66.122772,"median":-44.900923,"eighty":-32.516607,"marketCap":1931684861},{"date":"2021-05-21","current":-25.890379,"twenty":-65.671244,"median":-44.480809,"eighty":-32.358803,"marketCap":1779135057},{"date":"2021-05-28","current":-23.242499,"twenty":-64.694147,"median":-44.386565,"eighty":-31.303655,"marketCap":1597178063},{"date":"2021-06-04","current":-20.032948,"twenty":-64.610689,"median":-44.031597,"eighty":-30.285967,"marketCap":1376624130},{"date":"2021-06-11","current":-20.862082,"twenty":-64.558027,"median":-43.570722,"eighty":-29.527991,"marketCap":1433600563},{"date":"2021-06-18","current":-20.741724,"twenty":-64.212268,"median":-42.495297,"eighty":-28.292677,"marketCap":1425329790},{"date":"2021-06-25","current":-21.330142,"twenty":-63.820677,"median":-41.92895,"eighty":-27.567428,"marketCap":1465764678},{"date":"2021-07-02","current":-18.56859,"twenty":-63.563049,"median":-40.880837,"eighty":-26.338379,"marketCap":1275996398},{"date":"2021-07-09","current":-19.05671,"twenty":-63.346293,"median":-40.356867,"eighty":-25.927824,"marketCap":1309538976},{"date":"2021-07-16","current":-18.983157,"twenty":-63.064434,"median":-39.402534,"eighty":-24.897426,"marketCap":1304484615},{"date":"2021-07-23","current":-22.77444,"twenty":-62.996327,"median":-39.061665,"eighty":-22.736995,"marketCap":1565013948},{"date":"2021-07-30","current":-21.423754,"twenty":-62.617224,"median":-38.191382,"eighty":-22.318416,"marketCap":1472197501},{"date":"2021-08-06","current":-20.119873,"twenty":-62.196631,"median":-37.343558,"eighty":-22.065664,"marketCap":1382597466},{"date":"2021-08-13","current":-17.676423,"twenty":-61.713434,"median":-36.644994,"eighty":-22.03758,"marketCap":1487912878},{"date":"2021-08-20","current":-17.033544,"twenty":-61.40814,"median":-35.370549,"eighty":-21.66447,"marketCap":1433798546},{"date":"2021-08-27","current":-20.643556,"twenty":-61.0913,"median":-34.533005,"eighty":-21.423754,"marketCap":1737671334},{"date":"2021-09-03","current":-20.539157,"twenty":-60.148664,"median":-33.79505,"eighty":-21.362237,"marketCap":1728883537},{"date":"2021-09-10","current":-18.039072,"twenty":-59.562267,"median":-33.355548,"eighty":-21.228778,"marketCap":1518438911},{"date":"2021-09-17","current":-19.341314,"twenty":-59.20354,"median":-33.253081,"eighty":-20.910226,"marketCap":1628055123},{"date":"2021-09-24","current":-19.033611,"twenty":-57.533964,"median":-32.699398,"eighty":-20.745736,"marketCap":1602154246},{"date":"2021-10-01","current":-17.440151,"twenty":-56.073138,"median":-32.498788,"eighty":-20.681317,"marketCap":1468024704},{"date":"2021-10-08","current":-8.720075,"twenty":-55.733513,"median":-32.426222,"eighty":-20.33915,"marketCap":734012352},{"date":"2021-10-15","current":-8.934368,"twenty":-55.395739,"median":-31.977203,"eighty":-20.05702,"marketCap":752050463},{"date":"2021-10-22","current":-9.6267,"twenty":-55.070687,"median":-31.313219,"eighty":-19.592288,"marketCap":810327436},{"date":"2021-10-29","current":-9.659668,"twenty":-54.896793,"median":-31.28134,"eighty":-19.135611,"marketCap":813102530},{"date":"2021-11-05","current":-9.43988,"twenty":-54.595131,"median":-29.763099,"eighty":-18.972569,"marketCap":794601903},{"date":"2021-11-12","current":-7.657834,"twenty":-54.096156,"median":-29.527991,"eighty":-18.79624,"marketCap":751248869},{"date":"2021-11-19","current":-6.835326,"twenty":-53.456784,"median":-28.442844,"eighty":-18.666566,"marketCap":670559176},{"date":"2021-11-26","current":-6.617882,"twenty":-53.161294,"median":-28.201498,"eighty":-18.548531,"marketCap":649227418},{"date":"2021-12-03","current":-6.570611,"twenty":-53.053392,"median":-27.936468,"eighty":-18.184132,"marketCap":644590079},{"date":"2021-12-10","current":-6.52334,"twenty":-52.903151,"median":-27.280379,"eighty":-17.91197,"marketCap":639952740},{"date":"2021-12-17","current":-6.47607,"twenty":-52.38608,"median":-26.338379,"eighty":-17.539055,"marketCap":635315401},{"date":"2021-12-23","current":-6.490251,"twenty":-51.489304,"median":-26.061142,"eighty":-17.383006,"marketCap":636706603},{"date":"2021-12-31","current":-5.885188,"twenty":-50.620381,"median":-25.884108,"eighty":-16.989586,"marketCap":577348668},{"date":"2022-01-07","current":-4.750694,"twenty":-50.050635,"median":-25.08883,"eighty":-15.813722,"marketCap":466052539},{"date":"2022-01-14","current":-4.500159,"twenty":-49.533133,"median":-23.673783,"eighty":-10.067374,"marketCap":441474644},{"date":"2022-01-21","current":-4.192901,"twenty":-49.263626,"median":-23.205723,"eighty":-9.879455,"marketCap":411331942},{"date":"2022-01-28","current":-4.575792,"twenty":-48.949202,"median":-22.720947,"eighty":-9.659668,"marketCap":448894386},{"date":"2022-02-04","current":-4.651425,"twenty":-48.816067,"median":-22.30638,"eighty":-9.511311,"marketCap":456314128},{"date":"2022-02-11","current":-4.727058,"twenty":-48.544941,"median":-22.105783,"eighty":-9.209103,"marketCap":463733870},{"date":"2022-02-18","current":-4.741239,"twenty":-46.994903,"median":-22.06232,"eighty":-8.720075,"marketCap":465125071},{"date":"2022-02-25","current":-4.911414,"twenty":-46.680777,"median":-22.025545,"eighty":-8.38015,"marketCap":481819490},{"date":"2022-03-04","current":-3.715468,"twenty":-46.54883,"median":-21.68453,"eighty":-7.321268,"marketCap":364494821},{"date":"2022-03-11","current":-4.207082,"twenty":-46.38227,"median":-21.651097,"eighty":-6.817363,"marketCap":412723144},{"date":"2022-03-18","current":-3.5488,"twenty":-46.018986,"median":-21.423754,"eighty":-6.719986,"marketCap":396379721},{"date":"2022-03-25","current":-3.081521,"twenty":-45.93774,"median":-21.393664,"eighty":-6.518613,"marketCap":344187373},{"date":"2022-04-01","current":-3.052053,"twenty":-45.930633,"median":-21.330142,"eighty":-6.473234,"marketCap":340895964},{"date":"2022-04-08","current":-2.770001,"twenty":-45.765395,"median":-21.226726,"eighty":-6.38531,"marketCap":309392475},{"date":"2022-04-14","current":-2.517417,"twenty":-45.458018,"median":-21.04262,"eighty":-6.263352,"marketCap":281180395},{"date":"2022-04-22","current":-2.189058,"twenty":-45.061805,"median":-20.882142,"eighty":-5.916386,"marketCap":244504691},{"date":"2022-04-29","current":-1.934891,"twenty":-44.897885,"median":-20.772909,"eighty":-5.533494,"marketCap":216115702},{"date":"2022-05-06","current":-1.804212,"twenty":-44.660987,"median":-20.735037,"eighty":-4.940721,"marketCap":201519652},{"date":"2022-05-13","current":-1.818605,"twenty":-44.492947,"median":-20.675024,"eighty":-4.861307,"marketCap":217976210},{"date":"2022-05-20","current":-1.783178,"twenty":-44.427507,"median":-20.539157,"eighty":-4.769602,"marketCap":213729920},{"date":"2022-05-27","current":-1.798923,"twenty":-44.390814,"median":-20.236949,"eighty":-4.727058,"marketCap":215617160},{"date":"2022-06-03","current":-1.869778,"twenty":-44.38726,"median":-20.09647,"eighty":-4.660879,"marketCap":224109740},{"date":"2022-06-10","current":-1.806796,"twenty":-44.265356,"median":-19.832351,"eighty":-4.599428,"marketCap":216560780},{"date":"2022-06-17","current":-1.865842,"twenty":-44.043029,"median":-19.587722,"eighty":-4.48976,"marketCap":223637930},{"date":"2022-06-24","current":-2.149261,"twenty":-43.92505,"median":-19.423735,"eighty":-4.398055,"marketCap":257608249},{"date":"2022-07-01","current":-2.086279,"twenty":-43.696148,"median":-19.123575,"eighty":-4.259079,"marketCap":250059289},{"date":"2022-07-08","current":-2.133515,"twenty":-43.570722,"median":-19.033611,"eighty":-4.188174,"marketCap":255721009},{"date":"2022-07-15","current":-2.054788,"twenty":-43.210436,"median":-18.956686,"eighty":-4.131449,"marketCap":246284809},{"date":"2022-07-22","current":-2.326398,"twenty":-42.499738,"median":-18.802834,"eighty":-3.800555,"marketCap":278839698},{"date":"2022-07-29","current":-1.968188,"twenty":-42.490855,"median":-18.752811,"eighty":-3.519332,"marketCap":235904990},{"date":"2022-08-05","current":-2.428743,"twenty":-42.348715,"median":-18.643488,"eighty":-3.132037,"marketCap":291106757},{"date":"2022-08-12","current":-3.419717,"twenty":-41.92895,"median":-18.551874,"eighty":-3.127828,"marketCap":411624506},{"date":"2022-08-19","current":-3.332942,"twenty":-41.673552,"median":-18.429195,"eighty":-3.132037,"marketCap":401179593},{"date":"2022-08-26","current":-3.068673,"twenty":-41.268253,"median":-18.106841,"eighty":-3.132037,"marketCap":369370087},{"date":"2022-09-02","current":-3.025286,"twenty":-40.493421,"median":-18.000232,"eighty":-3.09836,"marketCap":364147631},{"date":"2022-09-09","current":-3.056841,"twenty":-40.439519,"median":-17.676423,"eighty":-3.078951,"marketCap":367945781},{"date":"2022-09-16","current":-2.737351,"twenty":-40.315362,"median":-17.547297,"eighty":-3.05542,"marketCap":329489512},{"date":"2022-09-23","current":-2.615078,"twenty":-39.706639,"median":-17.440151,"eighty":-3.025286,"marketCap":314771681},{"date":"2022-09-30","current":-2.607189,"twenty":-39.434302,"median":-17.204438,"eighty":-2.978743,"marketCap":313822143},{"date":"2022-10-07","current":-2.749184,"twenty":-39.331969,"median":-16.978597,"eighty":-2.906508,"marketCap":330913818},{"date":"2022-10-14","current":-2.591412,"twenty":-39.11669,"median":-16.159887,"eighty":-2.811504,"marketCap":311923068},{"date":"2022-10-21","current":-2.449417,"twenty":-39.058296,"median":-10.401451,"eighty":-2.765838,"marketCap":294831393},{"date":"2022-10-28","current":-2.658465,"twenty":-38.903329,"median":-10.069022,"eighty":-2.698697,"marketCap":319994137},{"date":"2022-11-04","current":-2.906957,"twenty":-38.326135,"median":-9.88495,"eighty":-2.664776,"marketCap":349904568},{"date":"2022-11-11","current":-3.352664,"twenty":-37.864261,"median":-9.780551,"eighty":-2.682131,"marketCap":403553437},{"date":"2022-11-18","current":-2.959349,"twenty":-37.65144,"median":-9.659668,"eighty":-2.686075,"marketCap":354053589},{"date":"2022-11-25","current":-2.712737,"twenty":-37.288534,"median":-9.560763,"eighty":-2.663198,"marketCap":324549123},{"date":"2022-12-02","current":-2.820133,"twenty":-36.852831,"median":-9.48109,"eighty":-2.653073,"marketCap":337397842},{"date":"2022-12-09","current":-1.980855,"twenty":-36.670634,"median":-9.428891,"eighty":-2.639197,"marketCap":236987483},{"date":"2022-12-16","current":-2.05643,"twenty":-36.454373,"median":-8.923379,"eighty":-2.628289,"marketCap":246029174},{"date":"2022-12-23","current":-2.028586,"twenty":-35.905158,"median":-8.720075,"eighty":-2.619811,"marketCap":242698024},{"date":"2022-12-30","current":-2.402482,"twenty":-35.421187,"median":-8.637655,"eighty":-2.610345,"marketCap":287430601},{"date":"2023-01-06","current":-1.833683,"twenty":-35.056154,"median":-7.657834,"eighty":-2.592607,"marketCap":219379979},{"date":"2023-01-13","current":-2.39055,"twenty":-34.755654,"median":-7.449844,"eighty":-2.578956,"marketCap":286002966},{"date":"2023-01-20","current":-2.899685,"twenty":-34.533005,"median":-6.927504,"eighty":-2.578326,"marketCap":346915411},{"date":"2023-01-27","current":-2.553632,"twenty":-33.943242,"median":-6.825872,"eighty":-2.578326,"marketCap":305513984},{"date":"2023-02-03","current":-2.8082,"twenty":-33.834353,"median":-6.759693,"eighty":-2.57169,"marketCap":335970206},{"date":"2023-02-10","current":-2.374639,"twenty":-33.755747,"median":-6.617882,"eighty":-2.567746,"marketCap":284099452},{"date":"2023-02-17","current":-2.32293,"twenty":-33.389496,"median":-6.532794,"eighty":-2.537722,"marketCap":277913032},{"date":"2023-02-24","current":-2.199624,"twenty":-33.33518,"median":-6.499705,"eighty":-2.513283,"marketCap":263160799},{"date":"2023-03-03","current":-2.434303,"twenty":-33.273641,"median":-6.47607,"eighty":-2.462582,"marketCap":291237629},{"date":"2023-03-10","current":-2.398505,"twenty":-33.254795,"median":-6.445344,"eighty":-2.433191,"marketCap":286954723},{"date":"2023-03-17","current":-2.785679,"twenty":-32.950851,"median":-6.286987,"eighty":-2.426673,"marketCap":321573171},{"date":"2023-03-24","current":-2.661687,"twenty":-32.766675,"median":-6.260988,"eighty":-2.433191,"marketCap":307259825},{"date":"2023-03-31","current":-2.355841,"twenty":-32.675325,"median":-5.979729,"eighty":-2.433191,"marketCap":271953572},{"date":"2023-04-06","current":-2.574893,"twenty":-32.61644,"median":-5.885188,"eighty":-2.432079,"marketCap":297240483},{"date":"2023-04-14","current":-3.331242,"twenty":-32.534426,"median":-5.67247,"eighty":-2.436272,"marketCap":384551893},{"date":"2023-04-21","current":-2.471742,"twenty":-32.489159,"median":-5.010682,"eighty":-2.444684,"marketCap":285332943},{"date":"2023-04-28","current":-2.376675,"twenty":-32.47311,"median":-4.937412,"eighty":-2.436272,"marketCap":274358599},{"date":"2023-05-05","current":-2.52339,"twenty":-32.418128,"median":-4.887778,"eighty":-2.444684,"marketCap":291295062},{"date":"2023-05-12","current":-2.755377,"twenty":-32.36554,"median":-4.821599,"eighty":-2.455267,"marketCap":313261575},{"date":"2023-05-19","current":-2.347198,"twenty":-32.127148,"median":-4.769602,"eighty":-2.455267,"marketCap":266855336},{"date":"2023-05-26","current":-3.013371,"twenty":-31.669668,"median":-4.745966,"eighty":-2.460955,"marketCap":342593215},{"date":"2023-06-02","current":-3.185237,"twenty":-31.410451,"median":-4.727058,"eighty":-2.462365,"marketCap":362132752},{"date":"2023-06-09","current":-3.170915,"twenty":-31.322783,"median":-4.684515,"eighty":-2.463378,"marketCap":360504457},{"date":"2023-06-16","current":-3.030558,"twenty":-31.294091,"median":-4.651425,"eighty":-2.466386,"marketCap":344547169},{"date":"2023-06-23","current":-2.864422,"twenty":-31.28134,"median":-4.613609,"eighty":-2.467433,"marketCap":325658950},{"date":"2023-06-30","current":-2.583708,"twenty":-31.28134,"median":-4.575792,"eighty":-2.47088,"marketCap":293744372},{"date":"2023-07-07","current":-2.509233,"twenty":-30.684116,"median":-4.495432,"eighty":-2.481662,"marketCap":285277240},{"date":"2023-07-14","current":-2.658183,"twenty":-29.993765,"median":-4.424526,"eighty":-2.491691,"marketCap":302211505},{"date":"2023-07-21","current":-2.618081,"twenty":-29.755926,"median":-4.329985,"eighty":-2.495636,"marketCap":297652280},{"date":"2023-07-28","current":-2.388928,"twenty":-29.663783,"median":-4.273261,"eighty":-2.481662,"marketCap":271599564},{"date":"2023-08-04","current":-2.01396,"twenty":-29.565387,"median":-4.192901,"eighty":-2.462473,"marketCap":235125761},{"date":"2023-08-11","current":-1.696938,"twenty":-29.121533,"median":-4.178719,"eighty":-2.436272,"marketCap":198114169},{"date":"2023-08-18","current":-1.617248,"twenty":-28.672121,"median":-4.131449,"eighty":-2.416802,"marketCap":188810464},{"date":"2023-08-25","current":-1.678188,"twenty":-28.42078,"median":-3.85728,"eighty":-2.403246,"marketCap":195925062},{"date":"2023-09-01","current":-1.748503,"twenty":-28.308617,"median":-3.715468,"eighty":-2.39221,"marketCap":204134212},{"date":"2023-09-08","current":-1.73444,"twenty":-28.256205,"median":-3.606135,"eighty":-2.389252,"marketCap":202492382},{"date":"2023-09-15","current":-1.495368,"twenty":-28.110318,"median":-3.499107,"eighty":-2.374639,"marketCap":174581270},{"date":"2023-09-22","current":-1.307861,"twenty":-28.104968,"median":-3.419717,"eighty":-2.36651,"marketCap":152690202},{"date":"2023-09-29","current":-1.425053,"twenty":-28.035428,"median":-3.379847,"eighty":-2.355841,"marketCap":166372119},{"date":"2023-10-06","current":-1.303174,"twenty":-27.788852,"median":-3.358296,"eighty":-2.336919,"marketCap":152142925},{"date":"2023-10-13","current":-1.157856,"twenty":-27.560997,"median":-3.350691,"eighty":-2.323624,"marketCap":135177347},{"date":"2023-10-17","current":-1.14848,"twenty":-27.548136,"median":-3.340831,"eighty":-2.315376,"marketCap":134082793},{"date":"2023-10-23","current":-1.120354,"twenty":-27.541705,"median":-3.332942,"eighty":-2.309926,"marketCap":130799133},{"date":"2023-11-01","current":-0.792217,"twenty":-27.331358,"median":-3.327109,"eighty":-2.297473,"marketCap":92489763},{"date":"2023-11-10","current":-1.408979,"twenty":-26.805518,"median":-3.277722,"eighty":-2.281287,"marketCap":165411307},{"date":"2023-11-17","current":-1.586268,"twenty":-26.420694,"median":-3.261222,"eighty":-2.232471,"marketCap":186224650},{"date":"2023-11-24","current":-1.553609,"twenty":-26.306283,"median":-3.250967,"eighty":-2.220308,"marketCap":182390613},{"date":"2023-12-01","current":-1.544278,"twenty":-26.154549,"median":-3.202423,"eighty":-2.191171,"marketCap":181295174},{"date":"2023-12-08","current":-1.51162,"twenty":-26.036351,"median":-3.190064,"eighty":-2.16973,"marketCap":177461137},{"date":"2023-12-15","current":-1.871051,"twenty":-25.927824,"median":-3.178344,"eighty":-2.145002,"marketCap":219657642},{"date":"2023-12-22","current":-2.168859,"twenty":-25.887871,"median":-3.169482,"eighty":-2.145002,"marketCap":254619757},{"date":"2023-12-29","current":-2.216938,"twenty":-25.880345,"median":-3.149387,"eighty":-2.148196,"marketCap":260264037},{"date":"2024-01-05","current":-2.013941,"twenty":-25.804515,"median":-3.14151,"eighty":-2.137684,"marketCap":236432632},{"date":"2024-01-12","current":-2.067361,"twenty":-25.452251,"median":-3.131782,"eighty":-2.122726,"marketCap":242704054},{"date":"2024-01-19","current":-1.821628,"twenty":-24.897426,"median":-3.114476,"eighty":-2.10257,"marketCap":213855510},{"date":"2024-01-26","current":-1.784234,"twenty":-24.123788,"median":-3.103801,"eighty":-2.080153,"marketCap":209465514},{"date":"2024-02-02","current":-1.74684,"twenty":-23.924529,"median":-3.09836,"eighty":-2.068796,"marketCap":205075519},{"date":"2024-02-09","current":-1.431661,"twenty":-23.253197,"median":-3.084193,"eighty":-2.059856,"marketCap":168074125},{"date":"2024-02-16","current":-1.567976,"twenty":-23.227789,"median":-3.068673,"eighty":-2.054788,"marketCap":191029679},{"date":"2024-02-23","current":-1.743698,"twenty":-23.168947,"median":-3.062767,"eighty":-2.048708,"marketCap":212438177},{"date":"2024-03-01","current":-1.937442,"twenty":-22.77444,"median":-3.054579,"eighty":-2.027233,"marketCap":236042419},{"date":"2024-03-08","current":-1.973487,"twenty":-22.720947,"median":-3.041063,"eighty":-2.019283,"marketCap":240433906},{"date":"2024-03-15","current":-2.009533,"twenty":-22.587216,"median":-3.027258,"eighty":-2.013941,"marketCap":244825393},{"date":"2024-03-22","current":-2.171737,"twenty":-22.32644,"median":-3.025286,"eighty":-2.01396,"marketCap":264587084},{"date":"2024-03-28","current":-2.149209,"twenty":-22.294344,"median":-3.022585,"eighty":-2.018218,"marketCap":261842405},{"date":"2024-04-05","current":-2.135692,"twenty":-22.179335,"median":-3.002957,"eighty":-2.019283,"marketCap":260195597},{"date":"2024-04-12","current":-2.351964,"twenty":-22.115144,"median":-2.966121,"eighty":-2.019283,"marketCap":286544518},{"date":"2024-04-19","current":-1.549954,"twenty":-22.073688,"median":-2.951242,"eighty":-2.019283,"marketCap":188833935},{"date":"2024-04-26","current":-1.820294,"twenty":-22.065664,"median":-2.919573,"eighty":-2.012047,"marketCap":221770087},{"date":"2024-05-03","current":-1.79806,"twenty":-22.060314,"median":-2.906957,"eighty":-2.002245,"marketCap":219061210},{"date":"2024-05-10","current":-1.780743,"twenty":-22.048279,"median":-2.899685,"eighty":-1.986466,"marketCap":223563337},{"date":"2024-05-17","current":-1.872624,"twenty":-22.013509,"median":-2.882412,"eighty":-1.973214,"marketCap":235098546},{"date":"2024-05-24","current":-1.767617,"twenty":-21.903849,"median":-2.863886,"eighty":-1.967539,"marketCap":221915450},{"date":"2024-05-31","current":-1.693237,"twenty":-21.762094,"median":-2.859625,"eighty":-1.946749,"marketCap":212577424},{"date":"2024-06-07","current":-1.653859,"twenty":-21.672494,"median":-2.837931,"eighty":-1.922257,"marketCap":207633763},{"date":"2024-06-14","current":-1.706363,"twenty":-21.66447,"median":-2.831478,"eighty":-1.913431,"marketCap":214225311},{"date":"2024-06-21","current":-1.621045,"twenty":-21.659121,"median":-2.822121,"eighty":-1.883588,"marketCap":203514045},{"date":"2024-06-28","current":-1.614482,"twenty":-21.648422,"median":-2.816213,"eighty":-1.881108,"marketCap":202690102},{"date":"2024-07-05","current":-1.583855,"twenty":-21.602954,"median":-2.808275,"eighty":-1.876164,"marketCap":198845032},{"date":"2024-07-12","current":-1.73699,"twenty":-21.49998,"median":-2.793082,"eighty":-1.86981,"marketCap":218070380},{"date":"2024-07-15","current":-1.995132,"twenty":-21.474572,"median":-2.792686,"eighty":-1.869825,"marketCap":250478825},{"date":"2024-08-02","current":-2.472038,"twenty":-21.449163,"median":-2.792289,"eighty":-1.869841,"marketCap":310352053},{"date":"2024-08-09","current":-2.380157,"twenty":-21.423754,"median":-2.783114,"eighty":-1.870812,"marketCap":298816844},{"date":"2024-08-16","current":-2.444986,"twenty":-21.402356,"median":-2.770001,"eighty":-1.872309,"marketCap":317491191},{"date":"2024-08-23","current":-2.368712,"twenty":-21.391658,"median":-2.74665,"eighty":-1.874014,"marketCap":307586787},{"date":"2024-08-30","current":-2.203453,"twenty":-21.374273,"median":-2.737351,"eighty":-1.877967,"marketCap":286127244},{"date":"2024-09-06","current":-2.038194,"twenty":-21.34619,"median":-2.713374,"eighty":-1.878868,"marketCap":264667700},{"date":"2024-09-13","current":-2.046669,"twenty":-21.290022,"median":-2.707247,"eighty":-1.879781,"marketCap":265768190},{"date":"2024-09-20","current":-1.08054,"twenty":-21.2475,"median":-2.694751,"eighty":-1.871995,"marketCap":140312398},{"date":"2024-09-27","current":-0.936468,"twenty":-21.224675,"median":-2.690714,"eighty":-1.868025,"marketCap":121604078},{"date":"2024-10-04","current":-0.800871,"twenty":-21.152279,"median":-2.686075,"eighty":-1.851139,"marketCap":103996248},{"date":"2024-10-11","current":-0.822058,"twenty":-21.029246,"median":-2.671132,"eighty":-1.839338,"marketCap":106747471},{"date":"2024-10-18","current":-0.813583,"twenty":-20.94767,"median":-2.663912,"eighty":-1.822225,"marketCap":105646982},{"date":"2024-10-25","current":-0.656799,"twenty":-20.900864,"median":-2.660076,"eighty":-1.814534,"marketCap":85287928},{"date":"2024-10-31","current":-0.559338,"twenty":-20.874118,"median":-2.658324,"eighty":-1.804768,"marketCap":72632300},{"date":"2024-11-08","current":-0.531383,"twenty":-20.836212,"median":-2.653073,"eighty":-1.799381,"marketCap":69885904},{"date":"2024-11-15","current":-0.431018,"twenty":-20.777809,"median":-2.648777,"eighty":-1.789493,"marketCap":56686225},{"date":"2024-11-22","current":-0.404739,"twenty":-20.745736,"median":-2.645155,"eighty":-1.7836,"marketCap":53230016},{"date":"2024-11-29","current":-0.439388,"twenty":-20.740387,"median":-2.640997,"eighty":-1.772944,"marketCap":57786928},{"date":"2024-12-06","current":-0.39185,"twenty":-20.729328,"median":-2.638744,"eighty":-1.764044,"marketCap":51534933},{"date":"2024-12-13","current":-0.370425,"twenty":-20.706491,"median":-2.630944,"eighty":-1.753658,"marketCap":48717132},{"date":"2024-12-20","current":-0.371596,"twenty":-20.693904,"median":-2.628201,"eighty":-1.748826,"marketCap":48871230},{"date":"2024-12-27","current":-0.58585,"twenty":-20.643556,"median":-2.626891,"eighty":-1.743698,"marketCap":77049238},{"date":"2025-01-03","current":-0.52308,"twenty":-20.561613,"median":-2.623388,"eighty":-1.740299,"marketCap":68793962},{"date":"2025-01-10","current":-0.477049,"twenty":-20.539945,"median":-2.622109,"eighty":-1.736656,"marketCap":62740093},{"date":"2025-01-17","current":-0.426834,"twenty":-20.440252,"median":-2.618081,"eighty":-1.731754,"marketCap":56135873},{"date":"2025-01-24","current":-0.477049,"twenty":-20.33915,"median":-2.615078,"eighty":-1.724505,"marketCap":62740093},{"date":"2025-01-31","current":-0.497973,"twenty":-20.246839,"median":-2.61161,"eighty":-1.719745,"marketCap":65491852},{"date":"2025-02-07","current":-0.464495,"twenty":-20.160447,"median":-2.603245,"eighty":-1.712323,"marketCap":61089038},{"date":"2025-02-14","current":-0.397541,"twenty":-20.101151,"median":-2.591419,"eighty":-1.705008,"marketCap":52283411},{"date":"2025-02-21","current":-0.377664,"twenty":-20.065044,"median":-2.589437,"eighty":-1.699238,"marketCap":49669240},{"date":"2025-02-28","current":-0.311756,"twenty":-19.992829,"median":-2.588983,"eighty":-1.693237,"marketCap":41001201},{"date":"2025-03-07","current":-0.297988,"twenty":-19.790189,"median":-2.582592,"eighty":-1.684825,"marketCap":39190544},{"date":"2025-03-14","current":-0.306581,"twenty":-19.619345,"median":-2.574893,"eighty":-1.676528,"marketCap":38988810},{"date":"2025-03-21","current":-0.319418,"twenty":-19.601421,"median":-2.569718,"eighty":-1.66975,"marketCap":40621387},{"date":"2025-03-28","current":-0.295695,"twenty":-19.553142,"median":-2.560793,"eighty":-1.658293,"marketCap":37604429},{"date":"2025-04-04","current":-0.307101,"twenty":-19.473187,"median":-2.553863,"eighty":-1.649484,"marketCap":39054996},{"date":"2025-04-11","current":-0.278347,"twenty":-19.301778,"median":-2.549335,"eighty":-1.632518,"marketCap":35398244},{"date":"2025-04-17","current":-0.333947,"twenty":-19.143635,"median":-2.545961,"eighty":-1.621045,"marketCap":42469068},{"date":"2025-04-25","current":-0.373674,"twenty":-19.123575,"median":-2.537799,"eighty":-1.614482,"marketCap":47521232},{"date":"2025-05-02","current":-0.407695,"twenty":-19.05671,"median":-2.533744,"eighty":-1.586268,"marketCap":51847776},{"date":"2025-05-09","current":-0.361174,"twenty":-19.033611,"median":-2.529305,"eighty":-1.581602,"marketCap":46167735},{"date":"2025-05-16","current":-0.413868,"twenty":-18.983157,"median":-2.517417,"eighty":-1.570553,"marketCap":52903470},{"date":"2025-05-23","current":-0.397569,"twenty":-18.956686,"median":-2.511065,"eighty":-1.565684,"marketCap":50820078},{"date":"2025-05-30","current":-0.398364,"twenty":-18.956686,"median":-2.506353,"eighty":-1.557344,"marketCap":50921707},{"date":"2025-06-06","current":-0.432066,"twenty":-18.934707,"median":-2.496748,"eighty":-1.552878,"marketCap":55229642},{"date":"2025-06-13","current":-0.459362,"twenty":-18.82811,"median":-2.487817,"eighty":-1.543345,"marketCap":58718900},{"date":"2025-06-20","current":-0.380343,"twenty":-18.792944,"median":-2.47189,"eighty":-1.512958,"marketCap":48618120},{"date":"2025-06-27","current":-0.379857,"twenty":-18.77646,"median":-2.466124,"eighty":-1.50092,"marketCap":48556013},{"date":"2025-07-03","current":-0.350661,"twenty":-18.756222,"median":-2.462147,"eighty":-1.491592,"marketCap":44823975},{"date":"2025-07-11","current":-0.391827,"twenty":-18.714233,"median":-2.447602,"eighty":-1.450134,"marketCap":50086092},{"date":"2025-07-18","current":-0.362189,"twenty":-18.666566,"median":-2.437584,"eighty":-1.426088,"marketCap":46297594},{"date":"2025-07-25","current":-0.402825,"twenty":-18.614916,"median":-2.427509,"eighty":-1.404313,"marketCap":51491958},{"date":"2025-08-01","current":-0.344478,"twenty":-18.57067,"median":-2.414415,"eighty":-1.331539,"marketCap":44033529},{"date":"2025-08-08","current":-0.378532,"twenty":-18.555217,"median":-2.40586,"eighty":-1.303174,"marketCap":48386632},{"date":"2025-08-15","current":-0.431453,"twenty":-18.495038,"median":-2.398505,"eighty":-1.264735,"marketCap":53355154},{"date":"2025-08-22","current":-0.500815,"twenty":-18.432593,"median":-2.391933,"eighty":-1.15223,"marketCap":62260379},{"date":"2025-08-29","current":-0.596426,"twenty":-18.345676,"median":-2.388928,"eighty":-1.089015,"marketCap":74146451},{"date":"2025-09-05","current":-0.519027,"twenty":-18.208309,"median":-2.380157,"eighty":-1.042346,"marketCap":64524393},{"date":"2025-09-12","current":-0.550897,"twenty":-18.13871,"median":-2.37319,"eighty":-0.933078,"marketCap":68486417},{"date":"2025-09-19","current":-0.45984,"twenty":-18.050794,"median":-2.368712,"eighty":-0.866974,"marketCap":57166348},{"date":"2025-09-26","current":-0.55545,"twenty":-17.747105,"median":-2.355841,"eighty":-0.844127,"marketCap":69052420},{"date":"2025-10-03","current":-0.655613,"twenty":-17.440151,"median":-2.334462,"eighty":-0.822058,"marketCap":81504496},{"date":"2025-10-10","current":-0.637402,"twenty":-17.000576,"median":-2.32293,"eighty":-0.803413,"marketCap":79240483},{"date":"2025-10-17","current":-0.802246,"twenty":-12.566359,"median":-2.305151,"eighty":-0.783981,"marketCap":99733618},{"date":"2025-10-24","current":-0.918602,"twenty":-9.887148,"median":-2.283098,"eighty":-0.769176,"marketCap":114198799},{"date":"2025-10-31","current":-0.96147,"twenty":-9.675053,"median":-2.271252,"eighty":-0.769176,"marketCap":119528076},{"date":"2025-11-07","current":-0.826742,"twenty":-9.475046,"median":-2.248334,"eighty":-0.769176,"marketCap":102778919},{"date":"2025-11-14","current":-0.924726,"twenty":-8.921181,"median":-2.231397,"eighty":-0.761005,"marketCap":114960124},{"date":"2025-11-21","current":-1.179508,"twenty":-8.591499,"median":-2.22349,"eighty":-0.761005,"marketCap":131835932},{"date":"2025-11-28","current":-1.238483,"twenty":-7.441335,"median":-2.211557,"eighty":-0.761005,"marketCap":138427729},{"date":"2025-12-05","current":-1.135276,"twenty":-6.800346,"median":-2.199624,"eighty":-0.761005,"marketCap":126892085},{"date":"2025-12-12","current":-1.201623,"twenty":-6.589519,"median":-2.180749,"eighty":-0.761005,"marketCap":134307856},{"date":"2025-12-19","current":-1.415409,"twenty":-6.494033,"median":-2.171737,"eighty":-0.761005,"marketCap":158203119},{"date":"2025-12-26","current":-1.643939,"twenty":-6.442035,"median":-2.161079,"eighty":-0.761005,"marketCap":183746331},{"date":"2026-01-02","current":-2.137858,"twenty":-6.278478,"median":-2.157134,"eighty":-0.761005,"marketCap":238952628},{"date":"2026-01-09","current":-2.034651,"twenty":-5.905987,"median":-2.135692,"eighty":-0.761005,"marketCap":227416984},{"date":"2026-01-16","current":-1.584963,"twenty":-5.16762,"median":-2.12668,"eighty":-0.761005,"marketCap":177154534},{"date":"2026-01-23","current":-1.629195,"twenty":-4.915196,"median":-2.117669,"eighty":-0.761005,"marketCap":182098382},{"date":"2026-01-30","current":-1.400665,"twenty":-4.804582,"median":-2.104755,"eighty":-0.761005,"marketCap":156555170},{"date":"2026-02-05","current":-1.695542,"twenty":-4.745021,"median":-2.093626,"eighty":-0.761005,"marketCap":189514153}],"updateTime":1770413619586},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRLD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608877526","title":"BUZZ-Prelude Therapeutics rises after FDA clears early-stage trial of blood cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2608877526","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608877526?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:29","pubTimestamp":1770128974,"startTime":"0","endTime":"0","summary":"BUZZ-Prelude Therapeutics rises after FDA clears early-stage trial of blood cancer drug** Shares of drug developer Prelude Therapeutics PRLD.O rise 6.85% to $2.13 premarket ** Company says U.S. FDA has cleared human testing of its experimental drug, PRT12396, for polycythemia vera and myelofibrosis — blood cancers where the body makes too many abnormal blood cells** PRLD says the early-stage study will assess safety and initial signs of benefit in patients with high-risk disease** PRT12396 is designed to target a genetic mutation common in both conditions - PRLD** Company expects to begin enrolling patients by Q2 2026 and says it has an exclusive option deal on the program with Incyte INCY.O ** Shares more than doubled in 2025  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL4N3YZ1FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4550","BK4532","BK4505","BK4585","INCY","PRLD","BK4588"],"gpt_icon":0},{"id":"2608725848","title":"BRIEF-Prelude Therapeutics Receives FDA Clearance Of Investigational New Drug Application (Ind) For Prt12396, A Mutant-Selective Jak2v617f Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2608725848","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608725848?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:04","pubTimestamp":1770127475,"startTime":"0","endTime":"0","summary":"BRIEF-Prelude Therapeutics Receives FDA Clearance Of Investigational New Drug Application (Ind) For Prt12396, A Mutant-Selective Jak2v617f InhibitorFeb 3 (Reuters) - Prelude Therapeutics Inc PRLD.O:PR","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA5029Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","PRLD","BK4139"],"gpt_icon":0},{"id":"2608894872","title":"Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (Ind) for PRT12396, a Mutant-Selective Jak2v617f Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2608894872","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608894872?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:00","pubTimestamp":1770127201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA5029Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","PRLD"],"gpt_icon":0},{"id":"2608874015","title":"Prelude Therapeutics Inc - to Dose First Patient by Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608874015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608874015?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:00","pubTimestamp":1770127201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA5029Z1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","PRLD"],"gpt_icon":0},{"id":"2606242560","title":"Prelude Therapeutics’ PRT2527 Trial Completion: What Investors Should Watch in Hematologic Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2606242560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606242560?lang=en_us&edition=fundamental","pubTime":"2026-01-27 00:31","pubTimestamp":1769445064,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC), Prelude Therapeutics, Inc. ($PRLD) announced an update on their ongoing clinical study. Study Overview: This Phase 1 clinic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-prt2527-trial-completion-what-investors-should-watch-in-hematologic-oncology?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-prt2527-trial-completion-what-investors-should-watch-in-hematologic-oncology?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRLD","BK4139","BK4211","ISBC","BK4505"],"gpt_icon":0},{"id":"2605142978","title":"Nasdaq Net Change Percentage Gainers & Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2605142978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605142978?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:30","pubTimestamp":1768948200,"startTime":"0","endTime":"0","summary":"Leverage 2X Lg IREN Dly     IREG     36.04     6.52     22.08        68,173. Defiance Dly Target 2X Lg   SMCX     13.76     2.47     21.88     6,989,430. GrShr 2x Long SMCI Daily    SMCL      5.46     0.97     21.60    14,233,848. Aimei Health Technology     AFJK     55.23     9.22     20.04       128,874. Airship AI Holdings         AISP      4.32     0.72     20.00     4,387,847. Defiance Lvg Lg+Incm SMCI   SMCC      6.98     0.94     15.53        84,793. Direxion Dly MU Bull 2X      MUU    157.33    21.04     15.44     2,306,047. Defiance Tgt 2X Shrt SMCI   SMCZ     42.75   -12.42    -22.51       638,309. Defiance Tgt 2X Lg DKNG     DKNX      8.37    -1.59    -15.95       265,114. Evolution Metals & Techs    EMAT      8.40    -1.52    -15.32       104,991. Defiance Tgt 2X Lg VST      VSTL     12.81    -2.30    -15.22       984,232. Defiance Tgt 2x Shrt IONQ   IONZ     16.27    -2.66    -14.05     3,905,099. Leverage 2x Lg FIG Dly      FIGG      2.80    -0.42    -13.04     1,155,398.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4170","SMCX","AFJK","BK4585","AXTI","AISP","LU1861220033.SGD","SMCC","IREG","DKNX","ABUS","LU0053671581.USD","LU1861215975.USD","EMAT","PRLD","QNCX","SMCL","SMCZ","CTMX","FIGG","IBRX","RKLZ","BK4588","DKNG","VSTL","IONZ","BK4543"],"gpt_icon":1},{"id":"2602737684","title":"Prelude Therapeutics unveils strategic investor presentation on pipelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2602737684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602737684?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:59","pubTimestamp":1767963565,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics ( ($PRLD) ) has shared an update. On January 9, 2026, Prelude Therapeutics began using a new corporate investor presentation o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-unveils-strategic-investor-presentation-on-pipelines?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-unveils-strategic-investor-presentation-on-pipelines?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","PRLD"],"gpt_icon":0},{"id":"2595713745","title":"Celsius Holdings Among 3 Value Stocks Trading Below Estimated Worth","url":"https://stock-news.laohu8.com/highlight/detail?id=2595713745","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595713745?lang=en_us&edition=fundamental","pubTime":"2025-12-30 19:07","pubTimestamp":1767092870,"startTime":"0","endTime":"0","summary":"As the United States market kicks off a holiday-shortened week with major stock indexes closing lower, investors are closely watching sectors like technology and precious metals, which have recently experienced notable declines. In this fluctuating environment, identifying stocks that are trading below their estimated worth can offer potential opportunities for value-seeking investors.","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/253891410-main-header/1756256225781","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/253891410-main-header/1756256225781"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-team/atlassian/news/celsius-holdings-among-3-value-stocks-trading-below-estimate","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-team/atlassian/news/celsius-holdings-among-3-value-stocks-trading-below-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CLFD","LU1720051108.HKD","ZYME","SRAD","BK4023","BK4585","BK4121","NIC","TEAM","BK4528","LU2357305700.SGD","BK4532","BK4613","BK4561","LU1548497426.USD","BK4198","LU1169590202.USD","PRLD","BK4548","BK7095","SDGR","CELH","LU1720051017.SGD","LU2211817866.USD","BK4566","NIC.AU","BK4211","BK4588","UMBF","LU1559883803.SGD","VERX","BK4020","IE0009356076.USD","LU2543165471.USD","BK4217","BLFS","BK4177","LU1815336091.USD","SMA","IE00B64QTZ34.USD","IE00BLDYK493.USD","LU0566484027.USD","LU2065731478.USD","LU0757428866.USD","BK4139","LU1169589451.USD","BK4150","CWBC","BK4167","BK4607"],"gpt_icon":0},{"id":"2595171315","title":"Bullish Prelude Therapeutics Insiders Rewarded As Their Investment Rises To US$2.75m","url":"https://stock-news.laohu8.com/highlight/detail?id=2595171315","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595171315?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:21","pubTimestamp":1767090092,"startTime":"0","endTime":"0","summary":"Insiders who bought Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) stock in the last 12 months were richly rewarded...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prld/prelude-therapeutics/news/bullish-prelude-therapeutics-insiders-rewarded-as-their-inve","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-prld/prelude-therapeutics/news/bullish-prelude-therapeutics-insiders-rewarded-as-their-inve","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BLSH","PRLD","BK4112","BK4505","BK4139"],"gpt_icon":0},{"id":"2592939749","title":"ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2592939749","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592939749?lang=en_us&edition=fundamental","pubTime":"2025-12-17 01:43","pubTimestamp":1765907029,"startTime":"0","endTime":"0","summary":"ADVISORY-Alert from Equity-Insider.com was published in error and has been withdrawnAn alert on cancer drug developers was inadvertently filed off a commentary by Equity-Insider.com and tagged to Immu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA1LWBBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNM","RLAY","PRLD","BK4139","BK4505","ONCY","BK4563","BK4007","CNTX"],"gpt_icon":0},{"id":"2592939613","title":"Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2592939613","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592939613?lang=en_us&edition=fundamental","pubTime":"2025-12-17 01:18","pubTimestamp":1765905480,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA1LWBBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRLD","BK4563","ONCY","BK4505","BK4139","IMNM","RLAY","CNTX","BK4007"],"gpt_icon":0},{"id":"2590355385","title":"Prelude Therapeutics Files for Resale From Time to Time of up to 6.3 Mln Shares of Voting Common Stock by Selling Stockholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2590355385","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590355385?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:19","pubTimestamp":1765401570,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG0YU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRLD","BK4505"],"gpt_icon":0},{"id":"2589882952","title":"Prelude Therapeutics Unveils Preclinical MPN Program Data at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589882952","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589882952?lang=en_us&edition=fundamental","pubTime":"2025-12-07 00:00","pubTimestamp":1765036814,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics Inc. presented new preclinical data from its myeloproliferative neoplasm  programs at the 2025 American Society of Hematology  Annual Meeting. The company disclosed its JAK2V617F-selective JH2 inhibitor, PRT12396, which has completed GLP toxicology studies and is on track for an IND filing in early 2026. Prelude also showcased a mutant calreticulin  targeted degrader antibody conjugate  with a novel CDK9 degrader payload. Both programs target the primary driver mutations in MPNs, aiming to offer disease-modifying therapies beyond current JAK2 inhibitors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prelude Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on Dece","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251206:nNDLFb0pQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014021.USD","LU2095319765.USD","BK4139","BK4112","SG9999014013.SGD","LU0314104364.USD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","PRLD","BK4505","SG9999014005.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2588341770","title":"Penny Stocks To Consider In December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588341770","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588341770?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:05","pubTimestamp":1764608718,"startTime":"0","endTime":"0","summary":"As December 2025 begins, U.S. stock indexes have slipped, with major tech and cryptocurrency-tied shares experiencing declines amid a broader risk-off sentiment in the market. Despite this cautious atmosphere, investors continue to explore opportunities beyond the well-known large-cap stocks. Penny stocks, though often considered a relic of past market eras, remain relevant for those seeking affordable entry points into companies with growth potential and strong financials.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9612016-choice2-main-header/1585186746976","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612016-choice2-main-header/1585186746976"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-doug/douglas-elliman/news/penny-stocks-to-consider-in-december-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate-management-and-development/nyse-doug/douglas-elliman/news/penny-stocks-to-consider-in-december-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4180","BK4173","LU1046422090.SGD","DOUG","LCUT","BK4139","BK4166","BK4509","DDL","BK4209","PRLD","BK4079","NAUT","BK4121","BK4526","BK4551","BK4023","BK4134","BK4531","LX","FINV","LU1235295612.USD","WDH","TUYA","BK4579","BK4113","BABB","BK4539","BK4505","CINT","LU0049112450.USD","MAPS"],"gpt_icon":0},{"id":"2583853414","title":"Prelude Therapeutics Advances Pipeline and Strengthens Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2583853414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583853414?lang=en_us&edition=fundamental","pubTime":"2025-11-13 12:39","pubTimestamp":1763008756,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics, Inc. ( ($PRLD) ) has released its Q3 earnings. Here is a breakdown of the information Prelude Therapeutics, Inc. presented to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-advances-pipeline-and-strengthens-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prelude-therapeutics-advances-pipeline-and-strengthens-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","PRLD","BK4139"],"gpt_icon":0},{"id":"2582375834","title":"Prelude Therapeutics reports third quarter net loss of $19.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375834","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582375834?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:02","pubTimestamp":1762948936,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics Inc. reported a net loss of $19.7 million, or $0.26 per share, for the three months ended September 30, 2025, compared to $32.3 million, or $0.43 per share, for the same period in 2024. Non-cash expenses related to share-based payments were $2.4 million, down from $5.9 million in the prior year period. As of September 30, 2025, cash, cash equivalents, restricted cash and marketable securities totaled $58.2 million. The company subsequently received an additional license payment from AbCellera in October 2025 and $60.0 million from Incyte in November 2025. Prelude anticipates that its current funds will support operations into 2027. The company also presented new preclinical data at the European Hematology Association 2025 Congress and will present updated data at the American Society of Hematology Annual Meeting in December 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL81FsCh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU2095319765.USD","BK4505","BK4112","LU2210150020.SGD","BK4550","LU2210149790.SGD","ABCL","IE00B3QW5Z07.USD","BK4588","BK4535","IE00BKPKM429.USD","INCY","PRLD","BK4139","IE00B64PRP62.GBP","BK4532","BK4585","IE00BGHQF748.EUR","NDAQ","LU0314104364.USD"],"gpt_icon":0},{"id":"2582373104","title":"BRIEF-Prelude Therapeutics Q3 EPS USD -0.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373104","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373104?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:01","pubTimestamp":1762948905,"startTime":"0","endTime":"0","summary":"BRIEF-Prelude Therapeutics Q3 EPS USD -0.26\n\n\nNov 12 (Reuters) - Prelude Therapeutics Q3 income from operations USD -20.418 million.\n\nQ3 operating expenses USD 26.918 million\nQ3 net income USD -19.725 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX505E6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRLD","BK4505","BK4139"],"gpt_icon":0},{"id":"2582237346","title":"Prelude Therapeutics Q3 Income From Operations USD -20.418 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582237346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582237346?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:01","pubTimestamp":1762948860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX505E6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRLD","BK4505","BK4139"],"gpt_icon":0},{"id":"2582388013","title":"Top News Today/Canada: Barrick's Interim CEO Gets to Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2582388013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582388013?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:30","pubTimestamp":1762810200,"startTime":"0","endTime":"0","summary":"Barrick Looks to Get Handle on North American Operations, Find Growth. Barrick Mining is diving into how its core gold operations in Nevada are being run and is looking for opportunities to boost production, steps that come after parting ways with its former chief executive.Mark Hill, Barrick's interim CEO, said that the mining company is determined to grow and not just replace the resources it digs up, and to produce gold and copper safely.Since taking on the role and being named chief operating officer in late September, Hill said he has met with Barrick's teams around the world. He also spent several weeks in Nevada, which alongside an asset in the Dominican Republic, is a focus of the company's review.Barrick Looking to Reset Safety Culture  Barrick Continues Efforts to Free Workers Jailed in Mali. Burger King Strikes Joint Venture to Double Presence in China. C2AE offers a range of engineering services to clients including state and local governments, transportation agencies, and ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLSN","SYPR","GIFI","PVLA","BK4179","QUIK","LPTH","MGNX","CLDX","ATOS","NMM","BK4079","BK4082","LU0205194284.USD","BK4109","PRLD","WHLM","MVIS","BK4539","SSTI","AMTX","GNPX","BK4139","BK4099","IE00BFMHRM44.USD","WKHS","BK4551","MGTX","BK4021","CENN","BK4137","SND","STXS","BK4505","KALV","DOX","BK4138","NRDE","BK4023","CRBU","LU0205193047.USD","ACCS","BK4134","IPSC","BK4547","EVI","ATRA","BK4168","FTHM"],"gpt_icon":1},{"id":"2580313997","title":"Prelude Therapeutics to Pause Development of Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2580313997","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580313997?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:50","pubTimestamp":1762260600,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics is pausing development in one of its cancer drug programs and will prioritize other programs, the company said Tuesday.The company will pause clinical development of its SMARCA2 selective degrader programs, saying it does not have the resources to explore the biologically complex mechanism fully in the timeframe needed.Prelude said it will prioritize development of its mutant selective JAK2V617F JH2 inhibitor and KAT6A selective degrader programs.The company said Tuesday it made an exclusive option agreement with Incyte to advance its mutant selective JAK2V617F JH2 inhibitor program for patients with myeloproliferative neoplasms.Through the agreement, Prelude will receive an upfront payment of $35 million, a $25 million equity investment and $100 million if the option is exercised.Prelude said its cash runway is now expected to extend into 2027 and could extend into the third quarter of 2028 if Incyte exercises its option.The company is also eligible to receive up ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Prelude Therapeutics to Pause Development of Cancer Drug","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRLD","BK4505","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}